Company Summary
Search
Home Page
 
*Eacom Timber Corporation 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
March 31DelistN
Board of Directors
NamePosition
(not available)
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
2/Apr/1980 5/Sep/2013 Canada   
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Timber Tract Operations  timber company 
  *Temporarily Unclassified  (not available) 
  *Consumer Products - Biotechnology/Pharmaceuticals  (not available) 
  *Research and Development in the Physical, Engineering and Life Sciences  Inflayzme is a Richmond, BC-based biopharmaceutical company focused on the dscovery, development and commercialization of drugs to treat serious inflammatory diseases such as asthma, rheumatoid arthritis, allergies, psoriasis and inflammatory bowl disease. 
Secondary  *Research And Development In The Life Sciences  (not available) 
Securities
SymbolSecurity NameMarketStatus
*ETR*Eacom Timber CorporationTSX VentureDELIST
*ETR.H*Eacom Timber CorporationTSX VentureDELIST
*IZP.H*Inflazyme Pharmaceuticals Ltd.TSX VentureDELIST
*IZP*Inflazyme Pharmaceuticals Ltd.TSEDELIST
*IZP*Inflazyme Pharmaceuticals Ltd.TSX VentureDELIST
*IZP*Inflazyme Pharmaceuticals Ltd.VSEDELIST
*IZP.WT*Inflazyme Pharmas Wt 9Se97VSEDELIST
*IZP.UN*Ut-Inflazyme Pharma LtdVSEDELIST
*IZP.RT*Inflazyme Pharmaceuticals Ltd rt 9se96VSEDELIST
*Inflazyme Pharmaceuticals Ltd rtVSEDELIST
*IZP.WT.A*Inflazyme Pharmaceuticals Ltd. wts A 9De94VSEDELIST
*Inflazyme Pharmaceuticals Ltd. wts A 8De94VSEDELIST
*Inflazyme Pharmaceuticals Ltd. wts A 9De94VSEDELIST
*DPH*Dalphine Enterprises Ltd.VSEDELIST
Name HistoryFromTo
*Eacom Timber Corporation26/Aug/20085/Sep/2013
*Inflazyme Pharmaceuticals Ltd.14/Nov/200725/Aug/2008
*Inflazyme Pharmaceuticals Ltd.10/Dec/199323/Jun/2000
*Dalphine Enterprises Ltd.2/Apr/19809/Dec/1993
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFRNot Received
Associations
Auditing Firm:  *Price Waterhouse Coopers LLP
  *PricewaterhouseCoopers LLP
Investor & Public Relastions:  *Dave Long
Investor & Public Relations:  *John Long
Investor Relations:  *Alan Davis
Sponsor:  *Oliver (C.M.) & Company Ltd
Subsidiary:  *Inflazyme Pharmaceuticals (Canada) Inc.
Transfer Agent:  *Montreal Trust Company of Canada (Vancouver)
  *Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  5/Sep/2013  NEWS RELEASE - DELIST OFFER TO PURCHASE[MARKET NEWS]
    NEWS RELEASE - IIROC TRADING HALT ETR[MARKET NEWS]
    NEWS RELEASE - HALT[MARKET NEWS]
Bulletins  5/Sep/2013  Delist-Offer to Purchase
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
Location Name: *Operating Location Area Name: * 
Effective Date: 27/Jun/1997 Location Ownership Percent: 100 
Expiry Date: 27/Dec/1997 Phone: (not available)
Address: 2660 Oak Street
Vancouver,British Columbia
Canada V6H 3Z6
North America
Fax: (not available)
Description:  
Location Name: *Operating Location (Richmond, BC) Area Name: * 
Effective Date: 1/Jul/1997 Location Ownership Percent: 100 
Expiry Date: 23/Jun/2000 Phone: (800) 315-3660 (primary)
Address: 425 - 5600 Parkwood Way
Richmond,British Columbia
Canada
North America
Fax: (604) 225-8711 (primary)
Description:  

* Historical Data